1 jan 2015 ano - (Varma et al., 2015)
Descrição:
The introduction of intravitreal vascular endothelial growth factor (VEGF) inhibition in 2006 hugely reduced legal blindness rates and achieved considerable improvements in vision in neovascular AMD and diabetic macular edema (DME)
Adicionado na linha do tempo:
Data:
~ 9 years and 4 months ago